PRE Logo

Prenetics Global Limited (PRE) 

NASDAQ
Market Cap
$70.86M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
474 of 959
Rank in Industry
30 of 52

Largest Insider Buys in Sector

PRE Stock Price History Chart

PRE Stock Performance

About Prenetics Global Limited

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic …

Insider Activity of Prenetics Global Limited

Over the last 12 months, insiders at Prenetics Global Limited have bought $0 and sold $0 worth of Prenetics Global Limited stock.

On average, over the past 5 years, insiders at Prenetics Global Limited have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $138,294 was made by ZWIENER DAVID K (director) on 2011‑06‑16.

List of Insider Buy and Sell Transactions, Prenetics Global Limited

2015-12-21SaleEVP & COO, PartnerRe Ltd
710
0.1805%
$139.11$98,770+0.74%
2015-09-17Saledirector
5,282
1.3362%
$138.46$731,338+0.81%
2015-09-16Saledirector
15,613
3.9498%
$138.46$2.16M+0.59%
2015-02-05SalePresident & CEO, PartnerRe NA
2,874
0.6357%
$121.06$347,933+13.82%
2014-11-28SaleCEO, PartnerRe Global
500
0.107%
$117.15$58,575+12.45%
2014-10-31SaleCEO, PartnerRe Global
2,000
0.4237%
$115.96$231,920+11.72%
2014-10-23SaleCEO, PartnerRe Global
500
0.1051%
$115.00$57,500+13.92%
2014-09-02SaleCEO, PartnerRe Global
500
0.1032%
$113.00$56,500+3.18%
2014-08-25SaleCEO, PartnerRe Global
500
0.1014%
$111.00$55,500+4.72%
2014-08-25Saledirector
5,549
1.1177%
$110.25$611,777+4.72%
2014-08-21Saledirector
1,719
0.3463%
$110.26$189,545+5.19%
2014-08-20Saledirector
2,441
0.4808%
$107.81$263,164+6.17%
2014-06-27SalePresident & CEO, PartnerRe NA
6,061
1.2%
$108.37$656,825+5.21%
2014-06-06SaleCEO, PartnerRe Global
150
0.0299%
$109.12$16,368+4.03%
2014-06-05SaleCEO, PartnerRe Global
500
0.0995%
$108.90$54,450+4.15%
2014-06-05SaleChief Accounting Officer
1,894
0.3745%
$108.21$204,955+4.15%
2014-05-23SaleCEO, PartnerRe Global
500
0.0986%
$107.90$53,950+5.93%
2014-05-02SaleCEO, PartnerRe Global
500
0.0977%
$106.90$53,450+5.83%
2014-04-29SaleCEO, PartnerRe Global
200
0.039%
$106.63$21,326+6.19%
2013-12-31SaleCEO, PartnerRe Global
300
0.058%
$105.90$31,770+2.61%

Insider Historical Profitability

3.9%
THIELE PATRICK AFormer Chief Executive Officer
213446
1.7471%
$5.80106+5.45%
ROLLWAGEN JOHN Adirector
13116
0.1074%
$5.80126+7.29%
PABST MARKEVP
12069
0.0988%
$5.8051+1.81%
ZWIENER DAVID Kdirector
5587
0.0457%
$5.8020<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.